EarningsQ3 2022 Earnings Report

Tandem Diabetes Care (TNDM) Q3 2022 Earnings Report

0 Followers

MX:TNDM Q3 2022 EPS Results

Actual EPS-$13.96

Consensus EPS-$1.21

Beat/MissMissed by -$12.75

One Year Ago EPS$1.65

Actual Revenue$3.76B

Expected Revenue$3.81B

Beat/MissMissed by -$56.04M

YoY Revenue Growth+13.87%

QuarterQ3 2022

Date11/02/2022

TimeAfter Close

Conference CallWednesday, November 2, 2022

MX:TNDM Upcoming Earnings

Tandem Diabetes Care's next earnings date is estimated for November 5, 2026, based on past reporting schedules.

MX:TNDM Q3 2022 Earnings Call

0:00 / 0:00

No slide deck is available for this earnings event.

No earnings call summary is available for this earnings event.

Report Date	Fiscal Quarter	Forecast / EPS	Last Year's EPS	EPS YoY Change
Nov 05, 2026	2026 (Q3)	-4.50 / -	-5.751	―
Aug 06, 2026	2026 (Q2)	-5.90 / -5.64	-8.856	36.31% (+3.22)
May 07, 2026	2026 (Q1)	-8.16 / -5.48	-12.292	55.46% (+6.82)
Feb 19, 2026	2025 (Q4)	-1.71 / -0.17	0.184	-190.00% (-0.35)
Nov 06, 2025	2025 (Q3)	-6.05 / -5.75	-6.431	10.57% (+0.68)
Aug 06, 2025	2025 (Q2)	-7.33 / -8.86	-8.636	-2.55% (-0.22)
Apr 30, 2025	2025 (Q1)	-11.12 / -12.29	-11.943	-2.92% (-0.35)
Feb 26, 2025	2024 (Q4)	-3.75 / 0.18	-8.452	102.17% (+8.64)
Nov 06, 2024	2024 (Q3)	-7.40 / -6.43	-9.371	31.37% (+2.94)
Aug 01, 2024	2024 (Q2)	-9.83 / -8.64	-10.106	14.55% (+1.47)

The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.

Beat

Missed